» Articles » PMID: 38901535

Contribution of Circulating Mfge8 to Human T2DM and Cardiovascular Disease

Abstract

MFGE8 is a major exosome (EV) protein known to mediate inflammation and atherosclerosis in type 2 diabetes mellitus (T2DM) in animal studies. The pathophysiological role of this protein in obesity, T2DM, and cardiovascular disease is less investigated in humans. Earlier we reported a rare Asian Indian population-specific missense variant (rs371227978; Arg148His) in the MFGE8 gene associated with increased circulating Mfge8 and T2DM. We have further investigated the role of Mfge8 with T2DM risk in additional Asian Indians (n = 4897) and Europeans and other multiethnic cohorts from UK Biobank (UKBB) (n = 455,808) and the US (n = 1150). We also evaluated the exposure of Mfge8-enriched human EVs in zebrafish (ZF) for their impact on cardiometabolic organ system. Most individual carriers of Arg148His variant not only had high circulating Mfge8 but also revealed a positive significant correlation with glucose (r = 0.42; p = 4.9 × 10), while the non-carriers showed a negative correlation of Mfge8 with glucose (r = -0.38; p = 0.001) in Asian Indians. The same variant was monomorphic in non-South Asian ethnicities. Even without the variant, serum Mfge8 correlated significantly with blood glucose in other non-South Asian ethnicities (r = 0.47; p = 2.2 × 10). Since Mfge8 is an EV marker, we tested the exposure of Mfge8-enriched human EVs to ZF larvae as an exploratory study. The ZF larvae showed rapid effects on insulin-sensitive organs, developing fatty liver disease, heart hypertrophy and exhibiting redundant growth with poor muscular architecture with and without the high-fat diet (HFD). In contrast, the control group fishes developed fatty liver disease and heart hypertrophy only after the HFD feeding. Backed with strong support from animal studies on the role of Mfge8 in obesity, insulin resistance, and atherosclerosis, the current research suggests that circulating Mfge8 may become a potential marker for predicting the risk of T2DM and cardiovascular disease in humans.

Citing Articles

The role of splicing events in the inflammatory response of atherosclerosis: molecular mechanisms and modulation.

Wang A, Wang C, Xuan B, Sun Y, Li B, Zhao Q Front Immunol. 2025; 15:1507420.

PMID: 39742258 PMC: 11685076. DOI: 10.3389/fimmu.2024.1507420.


Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion.

Rout M, Vaughan A, Sidorov E, Sanghera D J Clin Med. 2024; 13(19).

PMID: 39407977 PMC: 11477941. DOI: 10.3390/jcm13195917.

References
1.
Ruotsalainen S, Surakka I, Mars N, Karjalainen J, Kurki M, Kanai M . Inframe insertion and splice site variants in MFGE8 associate with protection against coronary atherosclerosis. Commun Biol. 2022; 5(1):802. PMC: 9385630. DOI: 10.1038/s42003-022-03552-0. View

2.
Sapkota B, Sanghera D . A rare missense variant in the milk fat globule-EGF factor 8 (MFGE8) increases T2DM susceptibility and cardiovascular disease risk with population-specific effects. Acta Diabetol. 2020; 57(6):733-741. PMC: 10502938. DOI: 10.1007/s00592-019-01463-x. View

3.
Cooper R, Tayo B, Zhu X . Genome-wide association studies: implications for multiethnic samples. Hum Mol Genet. 2008; 17(R2):R151-5. PMC: 2782359. DOI: 10.1093/hmg/ddn263. View

4.
Bu H, Zuo X, Wang X, Ensslin M, Koti V, Hsueh W . Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest. 2007; 117(12):3673-83. PMC: 2075476. DOI: 10.1172/JCI31841. View

5.
Martin A, Kanai M, Kamatani Y, Okada Y, Neale B, Daly M . Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019; 51(4):584-591. PMC: 6563838. DOI: 10.1038/s41588-019-0379-x. View